German Pharma Stock News

RENK Group (XTRA:R3NK) is back in focus after confirming 2026 revenue guidance above €1.5b alongside its first quarter results, which showed sales of €283.61 million and net income of €15.35 million. See our latest analysis for RENK Group. Despite confirming revenue guidance above €1.5b, RENK Group’s recent momentum has softened, with the share price at €45.11, the 30 day share price return down 13.35%, and the 1 year total shareholder return down 18.41%. If you are weighing RENK Group’s...

Siemens Energy AG ( ETR:ENR ) missed earnings with its latest second-quarter results, disappointing overly-optimistic...

Last week saw the newest quarterly earnings release from 1&1 AG ( ETR:1U1 ), an important milestone in the company's...

Siemens Healthineers (XTRA:SHL) received FDA clearance in the US for six new Artis interventional imaging systems featuring the Optiq AI imaging chain with deep-learning-based noise reduction. The company also secured renewed CDC HoSt-TT program certification for its Atellica IM Testosterone II assay, confirming its measurement accuracy in hormone testing. For readers tracking medical technology, Siemens Healthineers sits at the intersection of advanced imaging and diagnostic testing, two...

First quarter earnings set the tone for Jungheinrich Jungheinrich (XTRA:JUN3) opened the new financial year with first quarter results showing sales of €1,272 million and net income of €26.2 million, both lower than the same period a year earlier. See our latest analysis for Jungheinrich. The Q1 earnings update has come against a weak share price backdrop, with Jungheinrich’s stock down 29.1% on a year to date share price return and the 1 year total shareholder return also declining 25.7%...

Ströer SE & Co. KGaA ( ETR:SAX ) last week reported its latest quarterly results, which makes it a good time for...

The European market has recently experienced a volatile period, with the pan-European STOXX Europe 600 Index showing modest gains amid easing geopolitical tensions and strong corporate earnings, though tempered by tariff threats from the U.S. In this environment, dividend stocks can be an attractive option for investors seeking steady income streams and potential portfolio enhancement, especially as they offer a measure of stability against market fluctuations.

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

Last week, you might have seen that HOCHTIEF Aktiengesellschaft ( ETR:HOT ) released its first-quarter result to the...

Deutsche Lufthansa AG ( ETR:LHA ) just reported some strong earnings, and the market reacted accordingly with a healthy...

Q1 2026 earnings snapshot and what it means for Brenntag (XTRA:BNR) Brenntag (XTRA:BNR) opened 2026 with Q1 revenue of €3.7b and basic EPS of €0.68, setting a fresh reference point for investors lining up the latest numbers against a share price of €61.64. Over recent quarters the company has seen revenue move from €4.1b in Q1 2025 to €3.9b in Q4 2025 and then to €3.7b in Q1 2026, while quarterly basic EPS shifted from €0.93 to a loss of €0.20 and then to €0.68. With trailing net profit...

Merck KGaA (XTRA:MRK) has reported Q1 2026 revenue of €5.1b and basic EPS of €1.52, with the trailing twelve month figures sitting at €21.0b of revenue and EPS of €5.83. Over recent quarters, revenue has moved from €5.28b in Q1 2025 to €5.25b in Q2 2025, €5.32b in Q3 2025 and €5.25b in Q4 2025, while EPS shifted from €1.69 to €1.50, €2.07 and €0.73 across the same periods. This gives investors a clearer view of how the top and bottom line have tracked into this latest print. With a net profit...

RWE (XTRA:RWE) opened 2026 with Q1 revenue of €4.3b and net income of €20m, translating to basic EPS of €0.03, against a trailing twelve month EPS of €3.27 on revenue of €16.3b and net income of €2.4b. The company has seen quarterly revenue move from €6.4b in Q1 2025 to €4.3b in Q1 2026, while basic EPS shifted from €1.07 to €0.03 over the same period. Trailing margins settled at a net profit level of 14.5%, setting up this result as a test of how much short term earnings softness investors...

Why Uniper’s latest earnings matter for shareholders Uniper (XTRA:UN0) just released first quarter 2026 results, with sales of €17,414 million compared with €21,341 million a year earlier, while net income moved to €335 million from €85 million. Basic earnings per share from continuing operations came in at €0.8 compared with €0.2 a year ago, putting profitability at the center of the current discussion around the stock. See our latest analysis for Uniper. At a share price of €43.75, Uniper’s...

LEG Immobilien (XTRA:LEG) has opened Q1 2026 with total revenue of €367.7 million and basic EPS of €1.03, giving investors a fresh datapoint after a year of very large earnings swings that were heavily influenced by one off items. The company has seen quarterly revenue move from €515.9 million in Q4 2024 to a range between €351.4 million and €468.7 million across 2025, while basic EPS shifted between €0.81 and €9.08 over the same period. This underscores just how volatile the income line has...

Carl Zeiss Meditec (XTRA:AFX) has just posted its Q2 2026 numbers, with revenue at €524.0 million and basic EPS of €0.22, setting the tone for how investors might read the latest quarter. Over recent periods, revenue has moved between €560.0 million in Q2 2025 and €524.0 million in Q2 2026, while EPS has ranged from €0.52 in Q2 2025 to €0.22 in the latest quarter. This gives a clearer view of how the top line and per share earnings have tracked into this result. With trailing net profit...

BASF has commissioned a new fermentation plant at its BioHub facility for biological crop protection products. The company is highlighting its role in the Super Absorbent Polymer market, with a focus on sustainability driven applications. BASF is expanding its Safety Scouts farm safety education program as part of wider community engagement efforts. BASF (XTRA:BAS) is drawing attention for operational moves that sit outside headline earnings, from commissioning its BioHub fermentation plant...

thyssenkrupp (XTRA:TKA) has drawn investor attention after its latest reported figures highlighted annual revenue of €31,993.0 million and net income of €9.0 million. This has prompted a closer look at how the stock has been trading recently. See our latest analysis for thyssenkrupp. At a latest share price of €10.41, thyssenkrupp’s 1 day share price return of 5.15% and 30 day share price return of 24.05% suggest momentum has picked up recently. The 1 year total shareholder return of 48.91%...

The European market has recently seen modest gains, with the pan-European STOXX Europe 600 Index benefiting from easing geopolitical tensions and robust corporate earnings, although concerns about potential U.S. tariffs have tempered investor enthusiasm. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Why Deutsche Bank’s latest bond activity has caught investors’ attention Deutsche Bank (XTRA:DBK) has been active in May 2026, issuing and completing multiple fixed income offerings, including new senior unsecured notes with maturities stretching out to 2046 and a range of fixed coupons. This funding activity gives you a fresh data point on how the bank is raising long term capital, what kind of coupons it is willing to pay, and how its balance sheet mix between debt and equity might evolve...

Earnings context and what just changed AUTO1 Group (XTRA:AG1) has drawn investor attention after reporting first quarter 2026 results, with sales of €2,437.14 million and net income of €26.15 million, alongside record units sold and gross profit. See our latest analysis for AUTO1 Group. The first quarter update arrived alongside a sharp swing in sentiment, with a 1-day share price return of 12.90% and a 7-day share price return of 11.37%, even though the year to date share price return is...

PUMA (XTRA:PUM) is back in focus after appointing Mark Langer as Chief Financial Officer alongside releasing first quarter 2026 results. This combination gives investors fresh information on both leadership and earnings. See our latest analysis for PUMA. The recent CFO appointment and first quarter 2026 results come against a backdrop of improving share price momentum, with a 1 day share price return of 4.80%, a 90 day share price return of 11.63% and a 1 year total shareholder return of...

Why Hensoldt’s latest earnings matter for shareholders Hensoldt (XTRA:HAG) reported first quarter 2026 earnings with sales of €496 million, compared with €395 million a year earlier. The net loss improved to €19 million and basic loss per share to €0.16. See our latest analysis for Hensoldt. The first quarter update appears to have shifted sentiment in the short term, with a 1-day share price return of 3.95% to €74.3, even though the 90-day share price return is down 6.01% and the 5-year...

Adidas (XTRA:ADS) is back in the World Cup spotlight, unveiling its “Backyard Legends” campaign that digitally de ages Zidane, Beckham and Del Piero alongside Timothée Chalamet, Bad Bunny and Lionel Messi. See our latest analysis for adidas. The new World Cup campaign lands at a time when the stock’s 30 day share price return of 5.88% contrasts with a year to date decline of 13.98%. The 1 year total shareholder return is down 33.85%, pointing to near term momentum after a tougher longer term...